Ron Laufer
Director/Board Member at Adheron Therapeutics, Inc.
Profile
Ron started his career as a physician and epidemiologist, before moving into venture capital.
In 2001, he co-founded Lilly Ventures, the venture capital arm of Eli Lilly & Company.
Later he served as a managing director at Visium Asset Management, a healthcare-focused investment firm, before joining MedImmune Ventures in 2010.
He is currently or has been a board member of Adheron Therapeutics (acquired by Roche), Armaron Biosciences, Catabasis Pharmaceuticals (NASDAQ: CATB), G1 Therapeutics and VentiRx.
Ron received his B.Sci., M.D.
and M.P.H.
from Hebrew University, and an M.B.A.
from the Harvard Business School.
Ron Laufer active positions
Companies | Position | Start |
---|---|---|
Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Director/Board Member | - |
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Director/Board Member | - |
Former positions of Ron Laufer
Companies | Position | End |
---|---|---|
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Founder | 23/06/2010 |
LV Management Group, LLC
LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Founder | 30/09/2007 |
Armaron Bio Ltd.
Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Armaron Bio Ltd. operates a clinical stage biotechnology firm. It discovers, develops, and commercializes proprietary molecules to prevent heart failure, diabetes, and other serious diseases. The company is headquartered in Melbourne, Australia. | Director/Board Member | - |
G1 THERAPEUTICS, INC. | Director/Board Member | - |
ASTRIA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Ron Laufer
The Hebrew University of Jerusalem | Doctorate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ASTRIA THERAPEUTICS, INC. | Health Technology |
G1 THERAPEUTICS, INC. | Health Technology |
Private companies | 9 |
---|---|
LV Management Group, LLC
LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Finance |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Remon Medical Technologies, Inc.
Remon Medical Technologies, Inc. Medical SpecialtiesHealth Technology Remon Medical Technologies, Inc. develops and commercializes assessment and treatment implants. It has developed applications for patient management, post-operative monitoring, nerve and tissue stimulation and local drug delivery. The company was founded by Eyal Doron, Yariv Porat and Yossi Tzaliach in 1997 and is headquartered in Waltham, MA. | Health Technology |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
Visium Asset Management LP
Visium Asset Management LP Investment ManagersFinance Visium Asset Management LP is an independent hedge fund management firm founded by Jacob Gottlieb in 2005. Headquartered in New York City, the firm provides discretionary investment advisory services and sub-advisory services for various long/short equity, credit, event-driven and multi-strategy private investment funds, registered investment companies, an undertaking for collective investment in transferable securities organized under European Union Directors, and separately managed accounts. | Finance |
Nanostream, Inc.
Nanostream, Inc. BiotechnologyHealth Technology Nanostream, Inc. provides microfluidic analytical systems. The company develops microfluidic systems to automate routine laboratory procedures that are critical to research productivity. It furnishes the miniaturized plumbing critical to the future of pharmaceutical sciences. Nanostream was founded in 1999 and is headquartered in Pasadena, CA. | Health Technology |
Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Health Technology |
Armaron Bio Ltd.
Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Armaron Bio Ltd. operates a clinical stage biotechnology firm. It discovers, develops, and commercializes proprietary molecules to prevent heart failure, diabetes, and other serious diseases. The company is headquartered in Melbourne, Australia. | Electronic Technology |
VentiRx Pharmaceuticals, Inc.
VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Ron Laufer